528 related articles for article (PubMed ID: 24858274)
41. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's Disease.
Garza-Manero S; Pichardo-Casas I; Arias C; Vaca L; Zepeda A
Brain Res; 2014 Oct; 1584():80-93. PubMed ID: 24355599
[TBL] [Abstract][Full Text] [Related]
42. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
43. [Genetics of prevalent neurodegenerative disorders].
Lladó A; Gaig C; Molinuevo JL
Med Clin (Barc); 2006 May; 126(17):662-70. PubMed ID: 16759568
[TBL] [Abstract][Full Text] [Related]
44. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.
Abdelmaksoud NM; Sallam AM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Al-Noshokaty TM; Elrebehy MA; Elshaer SS; Mahmoud NA; Fathi D; Rizk NI; Elballal MS; Mohammed OA; Abdel-Reheim MA; Zaki MB; Saber S; Doghish AS
Pathol Res Pract; 2024 Jan; 253():155007. PubMed ID: 38061270
[TBL] [Abstract][Full Text] [Related]
45. MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities.
Abuelezz NZ; Nasr FE; AbdulKader MA; Bassiouny AR; Zaky A
Front Aging Neurosci; 2021; 13():743573. PubMed ID: 34712129
[TBL] [Abstract][Full Text] [Related]
46. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
47. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
Brennan S; Keon M; Liu B; Su Z; Saksena NK
Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
[TBL] [Abstract][Full Text] [Related]
48. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
49. Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression.
Krokidis MG; Exarchos TP; Vlamos P
Math Biosci Eng; 2021 Feb; 18(2):1813-1832. PubMed ID: 33757212
[TBL] [Abstract][Full Text] [Related]
50. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets.
Liu S; Fan M; Zheng Q; Hao S; Yang L; Xia Q; Qi C; Ge J
Biomed Pharmacother; 2022 Apr; 148():112681. PubMed ID: 35177290
[TBL] [Abstract][Full Text] [Related]
51. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.
López González I; Garcia-Esparcia P; Llorens F; Ferrer I
Int J Mol Sci; 2016 Feb; 17(2):206. PubMed ID: 26861289
[TBL] [Abstract][Full Text] [Related]
52. microRNA dysregulation in neurodegenerative diseases: A systematic review.
Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
[TBL] [Abstract][Full Text] [Related]
53. miRNA as an Ultimate and Emerging Diagnostic Approach for the Detection of Alzheimer's Disease.
Jain M; Agarwal S; Rana A; Tiwari A; Patil N
Microrna; 2023; 12(3):189-204. PubMed ID: 37859330
[TBL] [Abstract][Full Text] [Related]
54. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
Abdi F; Quinn JF; Jankovic J; McIntosh M; Leverenz JB; Peskind E; Nixon R; Nutt J; Chung K; Zabetian C; Samii A; Lin M; Hattan S; Pan C; Wang Y; Jin J; Zhu D; Li GJ; Liu Y; Waichunas D; Montine TJ; Zhang J
J Alzheimers Dis; 2006 Aug; 9(3):293-348. PubMed ID: 16914840
[TBL] [Abstract][Full Text] [Related]
55. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
56. Astrocytes: The Stars in Neurodegeneration?
Stoklund Dittlau K; Freude K
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540709
[TBL] [Abstract][Full Text] [Related]
57. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
Chudzik A; Śledzianowski A; Przybyszewski AW
Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
[TBL] [Abstract][Full Text] [Related]
58. Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases.
Li D; Li YP; Li YX; Zhu XH; Du XG; Zhou M; Li WB; Deng HY
Chin Med J (Engl); 2018 Sep; 131(18):2216-2225. PubMed ID: 30203797
[TBL] [Abstract][Full Text] [Related]
59. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
Qiu L; Zhang W; Tan EK; Zeng L
ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
[TBL] [Abstract][Full Text] [Related]
60. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases.
Maniati MS; Maniati M; Yousefi T; Ahmadi-Ahangar A; Tehrani SS
J Cell Biochem; 2019 Jun; 120(6):8908-8918. PubMed ID: 30663117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
